Essilor International (OTC:ESLOY) Stock Upgrade
Morgan Stanley has hiked shares of Essilor International (OTC:ESLOY) stock to a “Equal-weight” in a note issued today. ESLOY’s past rating was only a “Underweight”.
The stock decreased 2.43% or $1.59 on December 8, striking $63.92. Approximately shares of stock traded hands. Essilor International Cmpgn Gnl d’Opq SA (OTC:ESLOY) has risen 5.20% since May 6, 2015 and is uptrending. It has outperformed by 6.00% the S&P500.
Essilor International SA is an ophthalmic optics company. The company has a market cap of $28.33 billion. The Firm also develops and markets equipment for prescription laboratories, and instruments and services for eye care professionals. It currently has negative earnings. The Firm operates through three divisions: Lenses and Optical Instruments, Equipment and Sunglasses & Readers.
According to Zacks Investment Research, “Essilor International researches, develops, manufactures and markets around the world a wide range of lenses to improve and protect eyesight. It creates lenses for various types of visual disorders such as myopia, hypermetropia, presbyopia and stigmatism. The group’s know-how also covers the manufacture and sale of optical instruments mainly machines used to edge finished lenses and diagnose visual disorders. The Company sells its products through various flagship brands such as Varilux, Crizal, Essilor, Definity and Xperio. Essilor International is headquartered in Charenton-le-Pont, France.” Get a free copy of the Zacks research report on Essilor International Cmpgn Gnl d’Opq SA (ESLOY).